Clinical Trial

Efficacy of an Intraoperative Periradicular Application of Platelet Rich Fibrin (PRF) on the Intensity of Residual Post-surgical Neuropathic Pain After a Surgery for Disc Herniation

Study acronym: NeuroPRF
Recruiting Phase 3
View on ClinicalTrials.gov →
Summary
The prevalence of post-surgical lumbar neuropathic radiculopathy is approximately 30%. Poor response to the treatments recommended for neuropathic pain, namely antidepressants and/or gabapentinoids, requires the development of new techniques to prevent this chronic pain. Certain well-tolerated techniques, such as the administration of plasma enriched with platelets and fibrin (PRF), are increasingly used in regenerative medicine for their anti-inflammatory and analgesic properties. Thus, a periradicular intraoperative application of PRF may have an analgesic effect on the intensity of residual postsurgical neuropathic pain after disc herniation surgery.
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2022-01-18; most recent amendment 2026-06-05.
Status change: Not Yet Recruiting → Recruiting 2022-02-24
Trial Details
NCT Number NCT05196503
Lead Sponsor University Hospital, Strasbourg, France
Conditions Neuropathic Pain, Chronic Postsurgical Pain
Enrollment 60 participants
Start Date 2022-02-23
Primary Completion 2022-02-23 (estimated)
Study Completion 2028-01 (estimated)
Updated on ClinicalTrials.gov 2026-06-08